title: Sorafenib-induced eruption resembling pityriasis rubra pilaris.
authors.affiliation: Section of Dermatology, University of Chicago, Chicago, Illinois.
authors.forename: Carlos
authors.initials: C
authors.lastname: Paz
authors.affiliation: Section of Dermatology, University of Chicago, Chicago, Illinois.
authors.forename: Christiane
authors.initials: C
authors.lastname: Querfeld
authors.affiliation: Section of Dermatology, University of Chicago, Chicago, Illinois. Electronic address: cshea@medicine.bsd.uchicago.edu.
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Shea
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000009:adverse effects* / Q000627:therapeutic use; D001707:Biopsy, Needle; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D010916:Pityriasis Rubra Pilaris / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib